Diagnostic Value of Dual-Energy CT Virtual Non-Calcium and Rho/Z Images for Bone Marrow Infiltration in Primary Malignant Bone Tumors

Liu, Suwei; Pan, Haojie; Wu, Shaohua; Li, Shenglin; Sun, Jiachen; Li, Zhengxiao; Deng, Liangna

doi:10.1016/j.acra.2022.10.016

Cited by 5 publications

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…PMBCs are often aggressive tumors that can invade surrounding bone and the adjacent bone marrow; thus, it is imperative that they are evaluated and staged early. As bone-marrow composition changes with tumoral invasion, DECT can sensitively detect abnormal bone-marrow density [65].…”

Section: Primary Malignant Bone Cancersmentioning

confidence: 99%

Updates on the Applications of Spectral Computed Tomography for Musculoskeletal Imaging

Eibschutz,

Matcuk,

Chiu

et al. 2024

Diagnostics

View full text Add to dashboard Cite

Spectral CT represents a novel imaging approach that can noninvasively visualize, quantify, and characterize many musculoskeletal pathologies. This modality has revolutionized the field of radiology by capturing CT attenuation data across multiple energy levels and offering superior tissue characterization while potentially minimizing radiation exposure compared to traditional enhanced CT scans. Despite MRI being the preferred imaging method for many musculoskeletal conditions, it is not viable for some patients. Moreover, this technique is time-consuming, costly, and has limited availability in many healthcare settings. Thus, spectral CT has a considerable role in improving the diagnosis, characterization, and treatment of gout, inflammatory arthropathies, degenerative disc disease, osteoporosis, occult fractures, malignancies, ligamentous injuries, and other bone-marrow pathologies. This comprehensive review will delve into the diverse capabilities of dual-energy CT, a subset of spectral CT, in addressing these musculoskeletal conditions and explore potential future avenues for its integration into clinical practice.

show abstract

Section: Primary Malignant Bone Cancersmentioning

confidence: 99%